Rare Patient Voice President and Founder Wes Michael Inducted into DTC Hall of Fame
BOSTON, MA, April 21, 2022 – Wes Michael, President and Founder of Rare Patient Voice LLC, a leading search recruiting firm, was officially inducted into the DTC Hall of Fame on April 20, 2022. The DTC Hall of Fame is designed to honor individuals who have demonstrated extraordinary achievement in advancing patient communication. Industry-wide nominations are collected, then the final four inductees are determined by DTC Perspectives’ leadership and editorial teams.
“DTC marketing has been practiced successfully for over twenty years and over that time has become a very important part of the success of the pharmaceutical industry,” said Bob Ehrlich, CEO of DTC Perspectives. “It is important to recognize the people who have shaped DTC advertising and made significant contributions to communicating important health care information directly to patients.”
Wes Michael is part of the fourteenth annual class of inductees, who were honored live at an induction ceremony, sponsored by PatientPoint, at the DTC National Conference as part of Xpectives. Boston Health Summit. Other inductees in 2022 are Nancy Ibach, Associate Vice President US Oncology, Merck; Matt McNally, Global President, Dental Health; and Lisa M. Snider, Vice President, Strategic Marketing, Horizon Therapeutics.
“I’m proud to be part of the esteemed group that will be inducted this year,” said Michael. “It’s very special to be among such accomplished peers. My thanks to DTC National for this honor and for a great conference.
Michael founded Rare Patient Voice in 2013 with a mission to connect patients and caregivers to researchers for all types of research studies. RPV has since expanded from the United States to Canada, the United Kingdom, France, Germany, Italy, Spain and most recently Australia and New Zealand.
About Rare Patient Voice
Rare Patient Voice, LLC offers patients and caregivers the opportunity to participate in all types of research, including market research, health economics findings and real-world evidence, studies on the user experience/human factors and clinical trials. RPV has over 100,000 patients and caregivers for over 700 diseases, both rare and non-rare. Visit us at www.rarepatientvoice.com.